CSD-125

N/A

Report date: 2025/01/26 18:14:35
NME

Base Information

Drug NameCSD-125
Drug Alias NameCSD-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitorsMatrix metalloproteinase 9 inhibitorsIntegrin alpha-M antagonists +[4] 
TargetsIntegrin alpha-MMatrix metalloproteinase-2Cathepsin K +[4] 
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A